drugset
drugset / Trial / NCT05106101

L-glutamine Treatment in Patients With Diverticulosis

NCT05106101 ↗

Phase 1 Completed 9 enrolled Emmaus Medical, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.

Timeline

Start
2019-07-19
Primary completion
2022-12-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 15 g Oral

Indications

large intestine disorder